PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Riluzole and Sorafenib in patients with advanced solid tumors: a Phase I trial

Riluzole and Sorafenib in patients with advanced solid tumors: a Phase I trial
2023-04-12
(Press-News.org)

“Our phase I study determined the tolerable dose of this combination and investigated its biologic effects.” 

BUFFALO, NY- April 12, 2023 – A new research paper was published in Oncotarget's Volume 14 on April 10, 2023, entitled, “A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850.”

Overexpression of metabotropic glutamate receptor 1 (GRM1) has been implicated in the pathogenesis of multiple cancers. Riluzole, an inhibitor of glutamate release, showed synergistic antitumor activity in combination with the multi-kinase inhibitor sorafenib in preclinical models.

In a new phase I trial, researchers Kristen R. Spencer, Daniella E. Portal, Joseph Aisner, Mark N. Stein, Jyoti Malhotra, Weichung Shih, Nancy Chan, Ann W. Silk, Shridar Ganesan, Susan Goodin, Murugesan Gounder, Hongxia Lin, Jiadong Li, Robert Cerchio, Christina Marinaro, Suzie Chen, and Janice M. Mehnert from Rutgers University, Dana-Farber Cancer Institute, and the Perlmutter Cancer Center of NYU Langone Health identified the toxicity profile, dose-limiting toxicities, maximum tolerated dose (MTD), and pharmacokinetic and pharmacodynamic properties of riluzole combined with sorafenib in patients with advanced cancers.

“Riluzole functions as an inhibitor of GRM1 signaling through antagonism of glutamate release, and sorafenib is a multi-kinase inhibitor targeting both the MAPK and PI3K/AKT pathways through the inhibition of RAF1, ARAF and, to a lesser extent BRAF, as well as a set of tyrosine kinases including VEGFR. Our phase I study determined the tolerable dose of this combination and investigated its biologic effects.”

Patients with refractory solid tumors were enrolled utilizing a 3+3 dose-escalation design. Riluzole was given at 100 mg PO BID in combination with sorafenib, beginning at 200 mg PO daily and escalating in 200 mg increments per level in 28-day cycles. Restaging evaluations were performed every 2 cycles. In total, 35 patients were enrolled over 4 dose levels. 

The MTD was declared at dose level 3 (riluzole: 100 mg PO BID; sorafenib: 400 mg AM/200 mg PM). Pharmacokinetic analyses did not reveal definitive evidence of drug-drug interactions. Consistent decreases in phospho-forms of ERK and AKT in tumor tissue analyses with accompanying decrease in GRM1 expression and increase in pro-apoptotic BIM suggest target engagement by the combination. Best responses included a partial response in 1 (2.9%) patient with pancreatic acinar cell carcinoma with a KANK4-RAF1 fusion, and stable disease in 11 (36%) patients.

“Combination therapy with riluzole and sorafenib was safe and tolerable in patients with advanced solid tumors. The partial response in a patient with a RAF1 fusion suggests that further exploration in a genomically selected cohort may be warranted.”

 

Read the full research paper: DOI: https://doi.org/10.18632/oncotarget.28403 

Correspondence to: Janice M. Mehnert

Email: Janice.Mehnert@nyulangone.org 

Keywords: GRM1, riluzole, sorafenib, phase I, clinical trial

 

About Oncotarget: Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media:

Twitter  Facebook  YouTube  Instagram  LinkedIn  Pinterest  LabTube Soundcloud  

Click here to subscribe to Oncotarget publication updates.

For media inquiries, please contact: media@impactjournals.com.

 

Oncotarget Journal Office

6666 East Quaker Str., Suite 1A

Orchard Park, NY 14127

Phone: 1-800-922-0957 (option 2)

###

END


[Attachments] See images for this press release:
Riluzole and Sorafenib in patients with advanced solid tumors: a Phase I trial Riluzole and Sorafenib in patients with advanced solid tumors: a Phase I trial 2

ELSE PRESS RELEASES FROM THIS DATE:

COVID-19 increased weekday screentime for children: study

2023-04-12
The COVID-19 pandemic led to increased weekday screentime for school-aged children says a new study involving the University of Ottawa published in JAMA Pediatrics. Researchers examined the change in children’s screen time from prior to the pandemic to three separate pandemic waves between 2020 and 2021. Researchers found a boost of up to 1.35 hours per day during the weekdays compared to prior to the pandemic, particularly with school closures at the onset of the pandemic. While the weekend time was on par with pre-pandemic levels, ...

In search of a better semiconductor chip

In search of a better semiconductor chip
2023-04-12
A University of Texas at Arlington materials science and engineering researcher is working on a project to determine when failure happens in electronic device circuits. The research ultimately will help manufacturers design better semiconductor chips. Choong-Un Kim, professor in the Department of Materials Science and Engineering, was awarded a $285,0000 grant from the Semiconductor Research Corporation (SRC) for the project “Enabling Electromigration Solver for Solder Joint With Various Packaging Structures and Alloys.” This is the latest in a series of grants he has received from SRC that aims to answer the demand for improved device reliability. The SRC ...

All-optical quantum state sharing via continuous variable system

All-optical quantum state sharing via continuous variable system
2023-04-12
Quantum information is a powerful technology for increasing the amount of information that can be processed and communicated securely. Using quantum entanglement to securely distribute a secret quantum state among multiple parties is known as “quantum state sharing.” An important protocol in quantum networks and cryptography, quantum state sharing works like this (in simple terms): a secret quantum state is divided into n shares and given to n players. The secret state can only be reconstructed ...

Father’s alcohol consumption before conception linked to brain and facial defects in offspring

2023-04-12
According to the U.S. Surgeon General, women should not drink alcoholic beverages during pregnancy because of the risk of birth defects in their unborn child. Now, research at Texas A&M University demonstrates that a father’s alcohol consumption before conception also links to growth defects that affect the development of his offspring’s brain, skull and face.  Research investigating fetal alcohol syndrome (FAS) exclusively examines maternal alcohol exposure. However, because men drink more and are more likely to binge drink than women, Dr. Michael Golding, an associate ...

New technique allows researchers to dig into molecular causes of pediatric bipolar disorder

New technique allows researchers to dig into molecular causes of pediatric bipolar disorder
2023-04-12
It’s extremely difficult to study the biological basis of psychiatric disorders, in part because researchers can’t easily collect brain cells from living people to study in the laboratory. Now, University of Utah Health scientists have developed a way around that. The researchers grew three-dimensional structures, called “organoids”, derived from blood cells donated by a patient with pediatric bipolar disorder and by several family members. The approach identified significant molecular changes linked to the psychiatric condition. The results, reported in Molecular Psychiatry, suggest that structural changes in the ...

COVID-19 pandemic will disrupt cancer reporting for years to come

2023-04-12
Key takeaways: American College of Surgeons research published in JAMA Surgery reveals the complexities and variations that occurred in cancer reporting in the National Cancer Database (NCDB) because of the pandemic. The number of reported cancer cases in NCDB declined by 14.4% compared with prior years, representing more than 200,000 cancer cases that were not diagnosed and/or treated at accredited facilities. Research offers guidance to centers across the country on how to interpret data from 2020 and onwards. CHICAGO: New research from the American College of Surgeons (ACS) outlines significant ways that the COVID-19 pandemic destabilized usual patterns of cancer care as reported ...

Is the language you speak tied to outcome after stroke?

2023-04-12
MINNEAPOLIS – Studies have shown that Mexican Americans have worse outcomes after a stroke than non-Hispanic white Americans. A new study looks at whether the language Mexican American people speak is linked to how well they recover after a stroke. The study is published in the April 12, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology. “Our study found that Mexican American people who spoke only Spanish had worse neurologic outcomes three months after having a stroke than Mexican American people who spoke only English or were bilingual,” said study author ...

Archaeological sites at risk from coastal erosion on the Cyrenaican coast, Libya

Archaeological sites at risk from coastal erosion on the Cyrenaican coast, Libya
2023-04-12
Archaeological sites along the Libyan shoreline are at risk of being damaged or lost due to increasing coastal erosion, according to a study published April 12, 2023 in the open-access journal PLOS ONE by Kieran Westley and Julia Nikolaus of Ulster University, UK and colleagues. The Cyrenaican coast of Eastern Libya, stretching from the Gulf of Sirte to the current Egypt-Libya border, has a long history of human occupation back to the Palaeolithic era, and it therefore hosts numerous important and often ...

Poor family cohesion is associated with long-term psychological impacts in bereaved teenagers

Poor family cohesion is associated with long-term psychological impacts in bereaved teenagers
2023-04-12
The death of a parent can affect the health and well-being of children and adolescents, including higher risk of depression. A study published in PLOS ONE by Dröfn Birgisdóttir at Lund University, Lund, Sweden and colleagues suggests poor family cohesion is associated with long-term psychological symptoms among bereaved youth. Parentally bereaved children are at increased risk for mental illness including depression, anxiety, suicide attempts, and self-injurious behaviors. However, the relationship ...

The stripes of the Lesser Pacific Striped Octopus are as unique as our own fingerprints, enabling scientists to track individuals as they grow

The stripes of the Lesser Pacific Striped Octopus are as unique as our own fingerprints, enabling scientists to track individuals as they grow
2023-04-12
Article URL:  https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0265292 Article Title: Individually unique, fixed stripe configurations of Octopus chierchiae allow for photoidentification in long-term studies Author Countries: USA Funding: The authors received no specific funding for this work. END ...

LAST 30 PRESS RELEASES:

Existing drug has potential for immune paralysis

Soft brainstem implant delivers high-resolution hearing

Uncovering the structural and regulatory mechanisms underlying translation arrest

Scientists develop strategy to improve flexible tandem solar cell performance

Pushing boundaries: Detecting the anomalous Hall effect without magnetization in a new class of materials

Generative AI’s diagnostic capabilities comparable to non-specialist doctors

Some patients may experience durable disease control even after discontinuing immune checkpoint inhibitors for side effects

Native American names extend the earthquake history of northeastern North America

Lake deposits reveal directional shaking during devastating 1976 Guatemala earthquake

How wide are faults?

Key enzyme in lipid metabolism linked to immune system aging

Improved smoking cessation support needed for surgery patients across Europe

Study finds women much more likely to be aware of and have good understanding of obesity drugs

Study details role of protein that may play a key role in the development of schizophrenia

Americans don’t think bird flu is a threat, study suggests

New CDC report shows increase in autism in 2022 with notable shifts in race, ethnicity, and sex

Modulating the brain’s immune system may curb damage in Alzheimer’s

Laurie Manjikian named vice president of rehabilitation services and outpatient operations at Hebrew SeniorLife

Nonalcoholic beer yeasts evaluated for fermentation activity, flavor profiles

Millions could lose no-cost preventive services if SCOTUS upholds ruling

Research spotlight: Deer hunting season linked to rise in non-hunting firearm incidents

Rice scientists uncover quantum surprise: Matter mediates ultrastrong coupling between light particles

Integrative approach reveals promising candidates for Alzheimer’s disease risk factors or targets for therapeutic intervention

A wearable smart insole can track how you walk, run and stand

Research expands options for more sustainable soybean production

Global innovation takes center stage at Rice as undergraduate teams tackle health inequities

NIST's curved neutron beams could deliver benefits straight to industry

Finding friendship at first whiff: Scent plays role in platonic potential

Consortium of Multiple Sclerosis Centers releases 2025 expert panel document on best practices in MS management

A cool fix for hot chips: Advanced thermal management technology for electronic devices

[Press-News.org] Riluzole and Sorafenib in patients with advanced solid tumors: a Phase I trial